CO VID - 19 Vaccination Briefing - Professor Benjamin Cowie Executive Director, Senior Medical Advisor - Engagement and Partnerships - Victorian ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
COVID-19 Vaccination
Briefing
Professor Benjamin Cowie
Executive Director, Senior Medical Advisor - Engagement and Partnerships
COVID-19 Immunisation Program
Thursday, 22 April 2021
OFFICIAL
Three pillars of COVID-19 vaccine program
Access for all Highest levels of Public trust and
Victorians safety and quality confidence
Vaccines are free Vaccination sites are supported by Public information and messaging
comprehensive clinical safety and is clear, credible, consistent and
Easy to access for all eligible quality procedures easy to access
Victorians during each phase
Vaccination workforce is Broad and sustained engagement
Equitable access across appropriately trained and with stakeholders across sectors,
geography, social and cultural supervised community and government
groups
Data systems in place to underpin Local engagement activities
Services are appropriate for the monitoring, analysis and reporting enable information flow via
populations they are serving of safety, quality and adverse established professional and
events community networks
Workforce availability is sufficient
to maintain services Specialist services will manage
adverse events following
immunisation
OFFICIAL
Roles and Responsibilities
Victorian Vaccine
Commonwealth
Government Centers
Secure and purchase vaccines Commission and support Establish vaccine centers, outreach
establishment of vaccine clinics, and mobile models to administer
Approve vaccines (TGA) outreach and mobile models vaccines
Allocate, deliver and track vaccine Workforce identification and Manage vaccine product
products regulatory approval appropriately to minimise waste
Fund General Practice, pharmacy Setting state-based policy positions Complete reporting requirements to
and ACCHO sectors and approaches AIR and into CVMS
National booking system planned Monitor and ensure safety and Report adverse events through
(delayed) quality, manage adverse events existing pathways
Commission and oversee vaccination Provision of COVID vaccine Work with DH to communicate with
of private residential aged and management system (CVMS) priority cohorts and the community to
disability staff and residents create and manage demand
Communicate and engage at a state
Partner with jurisdictions to enable level Establish Specialist Immunisation
localisation and scale up Services
OFFICIAL
COVID-19 vaccine national roll-out strategy
(supply dependent)
Phase 1a – up to 1.4m doses Commenced 22 February 2021, ongoing
Phase 1a – up to 1.4m doses
Quarantine and border
70,000
workers
Phase 1b – up to 14.8m doses Commenced 22 March 2021
Frontline health care
worker sub-groups for 100,000 Elderly adults aged 80
1,045,000
prioritisation years and over Phase 2a – up to 15.8m doses
Elderly adults aged 70-
1,858,000
Aged care and disability 79 years Adults aged
318,000 2,650,000
care staff Other health care 60-69 years
953,000
workers Phase 2b – up to 16m doses
Adults aged
Aged care and disability Aboriginal and Torres 3,080,000
190,000 50-59 years
care residents Strait Islander people > 87,000
Balance of adult
55 6,643,000
Aboriginal and Torres population Phase 3 – up to 13.6m doses
Total 678,000 Strait Islander people 387,000
Younger adults with an
18- 54
underlying medical Catch up any
2,000,000 unvaccinated < 18 if recommended* 5,670,000
condition, including
those with a disability Other critical and high Australians from
453,000 previous phases
risk workers
Critical and high risk
workers including Total 6,570,000
defence, police, fire, 196,000
emergency services
and meat processing
Total 6,139,000 Population numbers are current estimates for each category.
* 16 and 17 year olds will be able to access the Pfizer vaccine in line with the relevant cohort.
Source – Australian Government
OFFICIAL
Phase 1a and 1b priority groups for scale-up in Victoria
Phase 1a sub-groups Phase 1b sub-groups
Cohort Cohort
Quarantine and border workers Health care workers (outside scope of 1a)
Frontline health care worker that are most at risk of Police
coming into contact with COVID-19 Fire protection & other emergency
Public aged care residents and staff Correction & detention services
Private aged care and disability care staff Meat/seafood processing
Private aged care and disability care residents Household contacts of high risk 1A (Hotel Quarantine/ Ports of
Entry/ Border workers)*
Residents of high risk accommodation*
Corrections clients*
Victoria’s assessment of Transport (including public transport/commercial)*
jurisdictional responsibility for
delivery to phase sub-groups: Adults younger than 70 with an underlying medical condition,
including those with a disability
Victorian Government Aboriginal and Torres Strait Islander people aged over 55
Adults over 70
Commonwealth Government
* Cohorts not in 1b but of interest to the state
OFFICIAL
Progress to date
Source: https://www.dhhs.vic.gov.au/coronavirus-covid-19-vaccine-data
Note This data does not encompass vaccine doses administered by the Australian Government.
All national data can be found on the Australian Government's Department of Health website.
OFFICIAL
COVID vaccine delivery models
Hospital
Hubs
COVID Vaccine
Clinics
Community Health Victoria’s
Vaccine Network COVID High Volume
Vaccine Vaccine Centres
System
General Practice,
COVID Vaccine ACCHOs, other
Teams
OFFICIAL
Commonwealth primary care reach and response
Wester Austin
n
Monas
h
GP Respiratory Clinics
GP Clinics
Aboriginal Controlled Community
Health Services
OFFICIALLocal Public Health Unit (LPHU) 'hub' catchments
Live from 22 Feb
✓ Barwon Health
✓ Austin Health
✓ Monash Health
✓ Western Health
Live from 1 Mar
✓ Ballarat Health Services
✓ Bendigo Health
Live from 9 Mar
✓ Goulburn Valley Health
✓ Albury Wodonga Health
✓ Latrobe Regional Hospital
OFFICIALVictorian high-volume vaccination centres: VIC-ICON centres
- Peak capacity ~ 50,000 people / week IF VACCINE AVAILABLE
Victorian Immunisation Centre – Integrated COVID-19 Open-access Network (VIC-ICON)
Initial sites – health services
• Repatriation Hospital Campus, Austin Health
• Sunshine Hospital, Western Health
Activated sites
• Melbourne Convention and Exhibition Centre (MCEC) – Melbourne Health
• Royal Exhibition Building – St Vincent’s Health
• Norlane (Geelong), Former Ford Factory – Barwon Health
• Mercure Ballarat
Soon to be activated site
• Melbourne Showgrounds
Find more information: https://www.coronavirus.vic.gov.au/high-volume-vaccination-centres
Images: Royal Exhibition Building - supplied
by St Vincent’s Hospital Melbourne
OFFICIALHigh-volume centres deliver the AstraZeneca
COVID-19 vaccine
From Wednesday 21 April 2021, people who are currently eligible to receive a COVID-19 vaccine
can book an appointment at a high-volume vaccination centre in Victoria.
Phase 1a and 1b groups (AstraZeneca)
• Deliver AstraZeneca vaccines to people under 50 years who have already had their first dose of AstraZeneca
without any severe adverse effects.
• Support those under 50 who would like to receive AstraZeneca through informed consent process.
• Deliver AstraZeneca vaccines to eligible 1a and 1b people aged 50 years and over.
• Deliver AstraZeneca Vaccines to all those aged 70 and over who wish to receive it (can book or walk-in)
Walk-ins are allowed at the high-volume vaccination centres although you are encouraged to book ahead by calling 1800 675 398.
Find more information: https://www.coronavirus.vic.gov.au/high-volume-vaccination-centres
OFFICIALTimeline of clinical notifications and ATAGI recommendations
March 2021: Overseas reports suggest a potential safety concern following AZ COVID-19 vaccination involving
cases of ‘thrombosis with thrombocytopenia syndrome’ (TTS) - a newly described serious condition with unusual
blood clots in the brain (cerebral venous sinus thrombosis) or in other parts of the body. These blood clots are
associated with low platelet levels and can cause serious long-term disability or death.
2 April 2021: a probable case had been reported in an Australian vaccine recipient, and ATAGI issued
an updated advice for healthcare providers warning to be alert for serious or ongoing side effects following
vaccination.
8 April 2021: ATAGI released updated recommendations about the AstraZeneca vaccine in response to further
evidence that it may be linked to this rare but serious side effect. ATAGI recommendations were updated to
reflect Pfizer vaccine as the preferred COVID-19 Vaccine (over AstraZeneca) in adults aged under 50
years.
OFFICIALRare side effect from AstraZeneca
There is evidence of rare but serious side effect involving thrombosis (blood clotting) after people receive
their first dose of AstraZeneca vaccine.
• The risk of developing this side-effect following receipt of the AstraZeneca vaccine is extremely rare.
• It is recommended that people who are aged over 50 years receive AstraZeneca. This advice is based
both on the increased risk of complications from COVID-19 with increasing age (and thus increased
benefit of vaccination), and the potentially lower, but not zero, risk of blood clotting (thrombosis with
thrombocytopenia syndrome) with increasing age.
• The new age-based recommendations are made out of an abundance of caution and the benefits of the
COVID-19 AstraZeneca vaccination outweigh the risks for the vast majority of people.
Find more information:
Patient information sheet on AstraZeneca COVID-19 vaccine and thrombosis with thrombocytopenia syndrome (TTS)
https://www.health.gov.au/resources/publications/patient-information-sheet-on-astrazeneca-covid-19-vaccine-and-thrombosis-with-thrombocytopenia-syndrome-tts
Multilingual consumer factsheet of AstraZeneca vaccine
https://www.health.gov.au/resources/publication/information-on-covid-19-astrzeneca-vaccine-other-languages
About the AstraZeneca vaccine
https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/learn-about-covid-19-vaccines/about-the-astrazeneca-covid-19-vaccine
OFFICIALATAGI advice on AstraZeneca vaccine (Under 50’s)
The Australian Technical Advisory Group (ATAGI) advised on 8 April that the Pfizer
vaccine is preferred over the AstraZeneca vaccine for people aged under 50 years.
First dose of AZ received Strongly encouraged to
without serious side receive the second dose
effects as planned
Under 50 years
Individual risk-benefit
consideration and
No doses received
informed consent
process *
*Based on advice there is evidence of rare but serious side effect involving thrombosis (blood clotting) after people
received the first dose of AstraZeneca vaccine
OFFICIALEngagement challenges and opportunities
Information:
Victorian Perception:
Logistics:
implementation of Pfizer V
Vaccine supply
Commonwealth AstraZeneca
program
www.coronavirus.vic.gov.au/vaccine
OFFICIALwww.coronavirus.vic.gov.au/vaccine
Available information resources
✓ Translated resources developed (by Victorian Department of Health)
• Subscribe online to receive weekly COVID-19 Vaccine Project Update from our communications team.
• During the vaccine rollout it is critical that we all continue to be COVIDSafe. Find out where to get tested.
✓ Resources developed by Australian Government Department of Health
• Find COVID-19 vaccine information in your languages
• Coronavirus (COVID-19) vaccine campaign resources
• COVID-19 vaccination decision guide for women who are pregnant, breastfeeding, or planning pregnancy (Last updated on 13 April 2021)
• https://www.health.gov.au/resources/publications/covid-19-vaccination-atagi-advice-on-influenza-and-covid-19-vaccines (ATAGI advice on Flu and Covid-19 vaccines)
• Updated ATAGI statement for healthcare providers on a specific clotting condition being reported after COVID-19 vaccination | Australian Government Department of Health
(Updated ATAGI Statement released on 8 April 2021)
• https://www.health.gov.au/resources/collections/covid-19-vaccination-easy-read-resources (Easy-read resources)
• Multilingual consumer factsheet about AstraZeneca vaccine / Multilingual consumer factsheet about Pfizer vaccine
• Visit www.health.gov.au/covid-19-vaccines to stay up-to-date.
• Coronavirus (COVID-19) - Vaccine Information: Translated Resources - GP videos
✓ Q&A (Find accurate and evidence-based answers to your questions about COVID-19 vaccines)
• https://www.health.gov.au/initiatives-and-programs/covid-19-vaccines/is-it-true
• COVID-19 vaccines: Frequently asked questions | NCIRS
• COVID-19 vaccine: Information for consumers and health professionals | Therapeutic Goods Administration (TGA)
• ASCIA - www.allergy.org.au/patients/ascia-covid-19-vaccination-faq
• Melbourne Vaccine Education Centre - mvec.mcri.edu.au/references/covid-19-vaccines-frequently-asked-questions/
OFFICIALMulticultural and Multilingual Video Resources
(Accurate as 21 April 2021)
Count of
Resource Language
Language sets
Aged care - Cliff's vaccine experience 8 https://www.health.gov.au/resources/video/cliff%E2%80%99s-aged-care-vaccine-experience-other-languages
Aged care - Nancy's vaccine experience 8 https://www.health.gov.au/resources/video/nancy%E2%80%99s-aged-care-vaccine-experience-other-languages
Aged care - Patricia's vaccine experience 8 https://www.health.gov.au/resources/video/patricia%E2%80%99s-aged-care-vaccine-experience-other-languages
Australia's COVID-19 vaccine supply 32 https://www.health.gov.au/resources/translated/australias-covid-19-vaccine-supply-animation-other-languages
COVID-19 vaccine animation 28 https://www.health.gov.au/resources/publications/covid-19-vaccines-animation-in-other-languages
Development times 32 https://www.health.gov.au/resources/translated/covid-19-vaccines-development-times-animation-other-languages
GP video - COVID-19 vaccine safety 18 https://www.health.gov.au/resources/video/covid-19-vaccine-safety-and-approval-process-other-languages
GP video - how vaccines work 18 https://www.health.gov.au/resources/video/how-covid-19-vaccines-work-other-languages
GP video - Vaccines are available for
18 https://www.health.gov.au/resources/video/covid-19-vaccines-are-available-for-everyone-in-australia-other-languages
everyone
How vaccines work 32 https://www.health.gov.au/resources/videos/covid-19-vaccines-how-vaccines-work-other-languages
Priority roll out 32 https://www.health.gov.au/resources/translated/covid-19-vaccines-priority-rollout-animation-other-languages
Stay informed about COVID-19 vaccines (15
5 https://www.health.gov.au/resources/translated/covid-19-vaccines-stay-informed-about-covid-19-vaccines-15-seconds-other-languages
seconds)
TGA approval process 32 https://www.health.gov.au/resources/translated/covid-19-vaccines-tga-approval-process-other-languages
OFFICIALYou can also read
